Nunna Ravi S, Khalid Syed, Chiu Ryan G, Parola Rown, Fessler Richard G, Adogwa Owoicho, Mehta Ankit I
Department of Neurosurgery, Swedish Medical Center, Seattle, WA, USA
Department of Surgery, Rush University Medical Center, Chicago, IL, USA.
Int J Spine Surg. 2022 Feb;16(1):88-94. doi: 10.14444/8198.
BACKGROUND: There is unclear evidence regarding the optimal surgical approach for multilevel cervical spondylotic myelopathy (CSM). The objective of this study was to compare complications, outcomes, and narcotic use in anterior discectomy and fusion (ACDF) vs posterior decompression and fusion (PCDF) in CSM patients. STUDY DESIGN: Registry-based retrospective cohort analysis. METHODS: Patients undergoing 3-level ACDF or PCDF for CSM between 2007 and 2017 were identified from the Humana Claims Database using relevant procedure codes. Propensity score-matched groups were compared in regards to complications, outcomes, and narcotic use. RESULTS: Propensity score matching generated equal cohorts of 6124 patients. The posterior fusion group had a higher rate of urinary tract infection (OR 2.47, < 0.0001), deep vein thrombosis (OR 1.90, < 0.0001), and pulmonary embolism (OR 1.75, < 0.0001). In regards to 30-day outcomes, the posterior approach demonstrated higher rates of stroke (OR 1.68, < 0.0001), wound dehiscence (OR 5.59, < 0.0001), Surgical site infection (SSI) (OR 4.76, < 0.0001), wound revision surgery (OR 3.02, < 0.0001), and all-cause readmission (OR 2.01, < 0.0001). One-year outcomes revealed higher rates of pseudarthrosis (4.7% vs 2.0%, OR 2.43, < 0.0001) and revision or extension surgery (OR 2.33, < 0.0001) in the posterior fusion cohort. These patients also demonstrated significantly higher mean morphine milligram equivalent used at 30 days (OR 1.19, < 0.0001), as well as 60 (OR 1.20, < 0.0001), 90 (OR 1.21, < 0.0001), and 120 (OR 1.21, < 0.0001) days. CONCLUSIONS: This nationwide propensity-matched analysis of multilevel CSM patients found the posterior approach to be associated with increased rates of inpatient complications, wound complications, 30-day readmission, 1-year pseudarthrosis, and 1-year revision or extension surgery. These patients also demonstrated higher levels of narcotic use up to 120 days after surgery. CLINICAL RELEVANCE: The posterior approach for treatment of CSM may be associated with increased rates of short- and long-term complications in addition to increased narcotic consumption in comparison to the anterior approach.
背景:关于多节段脊髓型颈椎病(CSM)的最佳手术方法,目前证据尚不明确。本研究的目的是比较CSM患者行前路椎间盘切除融合术(ACDF)与后路减压融合术(PCDF)后的并发症、治疗效果及麻醉药物使用情况。 研究设计:基于注册登记的回顾性队列分析。 方法:使用相关手术编码,从Humana索赔数据库中识别出2007年至2017年间因CSM接受三节段ACDF或PCDF手术的患者。对倾向评分匹配组的并发症、治疗效果及麻醉药物使用情况进行比较。 结果:倾向评分匹配产生了每组6124例患者的相等队列。后路融合组尿路感染发生率较高(比值比[OR] 2.47,P<0.0001)、深静脉血栓形成发生率较高(OR 1.90,P<0.0001)、肺栓塞发生率较高(OR 1.75,P<0.0001)。关于30天的治疗效果,后路手术显示中风发生率较高(OR 1.68,P<0.0001)、伤口裂开发生率较高(OR 5.59,P<0.0001)、手术部位感染(SSI)发生率较高(OR 4.76,P<0.0001)、伤口修复手术发生率较高(OR 3.02,P<0.0001)以及全因再入院发生率较高(OR 2.01,P<0.0001)。1年的治疗效果显示,后路融合队列中假关节形成发生率较高(4.7%对2.0%,OR 2.43,P<0.0001)以及翻修或延长手术发生率较高(OR 2.33,P<0.0001)。这些患者在30天时平均吗啡毫克当量使用量也显著更高(OR 1.19,P<0.0001),在60天(OR 1.20,P<0.0001)、90天(OR 1.21,P<0.0001)和120天(OR 1.21,P<0.0001)时也是如此。 结论:这项对多节段CSM患者进行的全国性倾向评分匹配分析发现,后路手术与住院并发症、伤口并发症、30天再入院、1年假关节形成以及1年翻修或延长手术的发生率增加相关。这些患者在术后120天内麻醉药物使用水平也更高。 临床意义:与前路手术相比,后路治疗CSM的方法可能不仅会增加短期和长期并发症的发生率,还会增加麻醉药物的消耗量。
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2025-2-15
Yale J Biol Med. 2018-3-28
Global Spine J. 2017-9
Spine (Phila Pa 1976). 2017-8-1